CSIMarket
 
Arcutis Biotherapeutics Inc   (NASDAQ: ARQT)
 

Arcutis Biotherapeutics Inc's Suppliers Performance

ARQT's Supply Chain




 
ARQT Costs vs Sales of Suppliers Growth Arcutis Biotherapeutics Inc recorded an increase in cost of sales by 46.01 % year on year, sequentially cost of sales grew by 11.8 % in Q2.

• More on ARQT Suppliers



Arcutis Biotherapeutics Inc recorded increase in cost of sales by 46.01 % year on year, sequentially cost of sales grew by 11.8 % in Q2.

• More on ARQT Suppliers




Arcutis Biotherapeutics Inc's Comment on Supply Chain


The company utilizes Contract Manufacturing Organizations (CMOs) to produce its commercial products and employs personnel and third-party consultants with technical and product development experience to manage these CMOs. The CMOs are required to comply with regulatory standards, including FDA Good Laboratory Practices (GLP), current Good Manufacturing Practices (cGMP), and International Council for Harmonization (ICH) guidelines. All CMO partners possess extensive technical expertise in manufacturing the company's specific technology. The company considers its supply arrangements adequate for current operations.

Arcutis Biotherapeutics Inc's Comment on Supply Chain


The company utilizes Contract Manufacturing Organizations (CMOs) to produce its commercial products and employs personnel and third-party consultants with technical and product development experience to manage these CMOs. The CMOs are required to comply with regulatory standards, including FDA Good Laboratory Practices (GLP), current Good Manufacturing Practices (cGMP), and International Council for Harmonization (ICH) guidelines. All CMO partners possess extensive technical expertise in manufacturing the company's specific technology. The company considers its supply arrangements adequate for current operations.







ARQT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Arcutis Biotherapeutics Inc 3,570.04 463.98 62.36 354
SUBTOTAL 0.00 0.00 0.00 -


Sources: Arcutis Biotherapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Arcutis Biotherapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.